SALV Salvarx Group Plc

TIDMSALV

RNS Number : 8421E

SalvaRx Group plc

09 July 2019

9 July 2019

SalvaRx Group plc

("SalvaRx" or the "Company")

Suspension of Trading

SalvaRx announces that trading in the Company's ordinary shares on AIM will be suspended with effect from 7.30 a.m. today.

The suspension is due to the Company not having made an acquisition or acquisitions which would constitute a reverse takeover under AIM Rule 14 ("Reverse Takeover"), or having been re-admitted to trading on AIM as an investing company under the AIM Rules, on or before the date falling six months from the Company's Annual General Meeting when it was classified as an AIM Rule 15 cash shell.

Trading in the Company's ordinary shares will remain suspended until the completion of a Reverse Takeover, which requires the publication of an admission document and the approval of such a transaction at a general meeting of the Company, or the Company is re-admitted to trading on AIM as an investing company. If no such transaction is completed within six months the Company's shares will be cancelled from trading on AIM pursuant to AIM Rule 41.

The Board continues to seek suitable opportunities for a Reverse Takeover and will make a further announcement at the appropriate time.

Enquiries

 
 SalvaRx Group plc                               Tel: +44 (0) 01624 
  Denham Eke                                           639396 
 SP Angel Corporate Finance LLP                   Tel: +44 (0) 20 
  Nominated Adviser and Broker                        3470 0470 
  Matthew Johnson / Jamie Spotswood (Corporate 
  Finance) 
  Abigail Wayne (Corporate Broking) 
 Peterhouse Corporate Finance Limited               Tel: +44 (0) 20 
  Joint Broker                                            7469 0932 
  Lucy Williams / Duncan Vasey 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

SRSUGUCWMUPBGCR

(END) Dow Jones Newswires

July 09, 2019 04:35 ET (08:35 GMT)

Salvarx (LSE:SALV)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024

Salvarx (LSE:SALV)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024